Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema
- 9 December 2019
- Vol. 75 (5), 1165-1177
- https://doi.org/10.1111/all.14144
Abstract
Background Recurrent angioedema (AE) is an important clinical problem in the context of chronic urticaria (mast cell mediator‐induced), ACE‐inhibitor intake and hereditary angioedema (both bradykinin‐mediated). To help patients obtain control of their recurrent AE is a major treatment goal. However, a tool to assess control of recurrent AE is not yet available. This prompted us to develop such a tool, the Angioedema Control Test (AECT). Methods After a conceptional framework was developed for the AECT, a list of potential AECT items was generated by a combined approach of patient interviews, literature review, and expert input. Subsequent item reduction was based on impact analysis, inter‐item‐correlation, additional predefined criteria for item performance, and a review of the item selection process for content validity. Finally, an instruction section was generated, and an US‐American‐English version was developed by a structured translation process. Results A 4‐item AECT with recall periods of 4 weeks and 3 months was developed based on 106 potential items tested in 97 patients with mast cell mediator‐induced (n=49) or bradykinin‐mediated recurrent AE (n=48). 84 items were excluded based on impact analysis. The remaining 22 items could be further reduced by a method‐mix of inter‐item‐correlation, additional predefined criteria for item performance, and review for content validity. Conclusions The AECT is the first tool to assess disease control in recurrent AE patients. Its retrospective approach, its brevitiy and its simple scoring make the AECT ideally suited for clinical practice and trials. Its validity and reliability need to be determined in future independent studies.Funding Information
- Shire (IIR‐DEU‐000874)
This publication has 23 references indexed in Scilit:
- Burden of Illness in Hereditary Angioedema: A Conceptual ModelActa Dermato-Venereologica, 2015
- Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in SwedenAllergy and Asthma Proceedings, 2014
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria controlJournal of Allergy and Clinical Immunology, 2014
- Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in EuropeOrphanet Journal of Rare Diseases, 2014
- The burden of illness in patients with hereditary angioedemaAnnals of Allergy, Asthma & Immunology, 2013
- Development, validation, and initial results of the Angioedema Activity ScoreAllergy, 2013
- Development and construct validation of the angioedema quality of life questionnaireAllergy, 2012
- Diagnostik und Ausschluss des hereditären AngioödemsDie Dermatologie, 2012
- Development of the asthma control test: A survey for assessing asthma controlJournal of Allergy and Clinical Immunology, 2004
- Clinical impact versus factor analysis for quality of life questionnaire constructionJournal of Clinical Epidemiology, 1997